Regarding the difference in the β-diversity between healthy subjects and RA patients, the PERMANOVA analysis showed a significant difference in phenotypes characterized by different disease activity and RF/ACPA status (Table 2). This evidence concerns the gene PRTN3 and rheumatoid arthritis.